FDA Okays Historic Blood Treatment for COVID; Clinical Trials to Use Antibodies From Recovered Patients
As the U.S. Food and Drug Administration (FDA) works to facilitate expedited access to several investigative drug interventions to treat COVID-19 patients, one particularly promising treatment is now set to enter clinical trials in New York. The convalescent plasma treatment…